Amikacin disposition in neonates: validation of a drug clearance population pharmacokinetic model

被引:0
|
作者
Scheers, I. [1 ]
Anderson, B. J. [2 ]
van den Anker, J. N. [3 ,4 ,5 ]
Cossey, V. [1 ]
Allegaert, K. [1 ]
机构
[1] Univ Hosp Gasthuisberg, Neonatal Intens Care Unit, B-3000 Louvain, Belgium
[2] Univ Auckland, Dept Anesthesiol, Auckland 1, New Zealand
[3] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA
[4] Childrens Natl Med Ctr, Div Pediat Clin Pharmacol 3, Washington, DC 20010 USA
[5] Sophia Childrens Univ Hosp, Erasmus MC, Dept Pediat 5, Rotterdam, Netherlands
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:16 / 16
页数:1
相关论文
共 50 条
  • [31] Population pharmacokinetic model of levetiracetam in Korean neonates with seizures
    Jung, Yun Seob
    Lee, Soon Min
    Park, Min Soo
    Park, Kyungsoo
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2018, 56 (05) : 217 - 223
  • [32] Maturation of the Glomerular Filtration Rate in Neonates, as Reflected by Amikacin Clearance
    De Cock, Roosmarijn F. W.
    Allegaert, Karel
    Schreuder, Michiel F.
    Sherwin, Catherine M. T.
    de Hoog, Matthijs
    van den Anker, Johannes N.
    Danhof, Meindert
    Knibbe, Catherijne A. J.
    CLINICAL PHARMACOKINETICS, 2012, 51 (02) : 105 - 117
  • [33] Limited predictability of amikacin clearance in extreme premature neonates at birth
    Allegaert, K
    Anderson, BJ
    Cossey, V
    Holford, NHG
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (01) : 39 - 48
  • [34] Maturation of the Glomerular Filtration Rate in Neonates, as Reflected by Amikacin Clearance
    Roosmarijn F. W. De Cock
    Karel Allegaert
    Michiel F. Schreuder
    Catherine M. T. Sherwin
    Matthijs de Hoog
    Johannes N. van den Anker
    Meindert Danhof
    Catherijne A. J. Knibbe
    Clinical Pharmacokinetics, 2012, 51 : 105 - 117
  • [35] A Population Pharmacokinetic Model Characterizing the Multiphasic Disposition of Intramuscular VIVITROL
    Pastoor, Devin
    Li, Wen-I
    Turncliff, Ryan
    Gobburu, Jogarao V. S.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S60 - S61
  • [36] Population pharmacokinetics of amikacin in Korean neonates.
    Shin, JG
    Yoon, YR
    Cha, IJ
    Shin, JB
    Jang, IJ
    Shin, SG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PII74 - PII74
  • [37] Validation of a Pediatric Population Pharmacokinetic Model for Vancomycin
    Hahn, Andrea
    Frenck, Robert W., Jr.
    Zou, Yuanshu
    Vinks, Alexander A.
    THERAPEUTIC DRUG MONITORING, 2015, 37 (03) : 413 - 416
  • [38] Model Validation Methods of Population Pharmacokinetic Models
    Lee, Eun-Kyung
    KOREAN JOURNAL OF APPLIED STATISTICS, 2012, 25 (01) : 139 - 152
  • [39] Assessment of Piperacillin-Tazobactam Population Pharmacokinetic Models in Neonates: An External Validation
    Chaudhari, Bhim Bahadur
    Batcha, Jaya Shree Dilli
    Raju, Arun Prasath
    Matcha, Saikumar
    Lewis, Leslie E.
    Moorkoth, Sudheer
    Mallayasamy, Surulivelrajan
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2025, 50 (01) : 81 - 89
  • [40] Physiologically Based Pharmacokinetic Modeling of Vancomycin and its Comparison with Population Pharmacokinetic Model in Neonates
    Cao, Ailing
    Li, Qiaoxi
    Han, Minzhen
    Liu, Qian
    Liang, Heng
    Tan, Lu
    Guan, Yanping
    JOURNAL OF CLINICAL PHARMACOLOGY, 2025, 65 (01): : 87 - 95